Medical Devices; Radiology Devices; Classification of the Vaginal Hydrogel Packing System
Key claim: The FDA is placing vaginal hydrogel packing systems in the moderate-risk (class II) device category with special controls, giving manufacturers a clearer, less burdensome path to market them.
Abstract
(Rule · Health and Human Services Department, Food and Drug Administration) The Food and Drug Administration (FDA) is classifying the vaginal hydrogel packing system into class II (special controls). The special controls that apply to the device type are identified in this order and will be part of the codified language for classification of the vaginal hydrogel packing system. We are taking this action because we have determined that classifying the device into class II will provide a reasonable assurance of the safety and effectiveness of the device. We believe this action will also enhance patients’ access to beneficial innovative devices, in part by reducing regulatory burdens.
Why this matters
Class II designation with special controls creates a 510(k) pathway for vaginal hydrogel packing systems—spacers used to protect healthy tissue during pelvic radiation therapy—rather than requiring the more onerous Class III premarket approval. That regulatory choice can shape how quickly comparable devices reach clinicians treating gynecologic cancers.